=46rom: Linda Carlton <[log in to unmask]>
To: [log in to unmask]
Subject: http://ourworld.compuserve.com/homepages/chronicwellness/nad=
hfaq.htm
Date: Tue, 17 Jun 1997 01:05:28 -0700
NADH FAQ's
Q. What is NADH?
A. NADH is the abbreviation for the reduced form of
nicotinamide-adenine-dinucleotide. This reduced form contains high en=
ergy
hydrogen (the H in NADH) that provides energy to the cell. NADH occur=
s in
all living cells and plays a central role in the energy production of=
the
cells(1). The more energy a cell needs, the more NADH it needs. For e=
xample,
muscle cells and brain cells contain about 50 micrograms NADH per gra=
m
tissue, heart cells 90 micrograms, red blood cells 4 micrograms(2). I=
n other
words, if you supply NADH to the body, it acts as an energy supplemen=
t,
which provides the organism with additional energy.
NADH occurs naturally in the muscle tissue of many animals, such as f=
ish,
poultry and cattle that are part of our diet (3).
Q. What does NADH do in the body?
A. NADH is the first and most energetic component in the central ener=
gy
producing mechanism in our cells(4). Thus it plays a crucial role in
supplying our cells with energy.
In addition NADH supplies the energy for the production of important
compounds in our cells. NADH increases the production of adrenaline a=
nd
dopamine, particularly in the brain(5, 6) It improves aspects of brai=
n and
central nervous system function which are related to the activity of
dopamine and adrenaline.
Q. How was NADH discovered?
A. NADH was discovered in 1934 by Kaplan, an American scientist who f=
ound
that it plays an essential role in the energy production of cells(7).
Q. Who should take NADH?
A. Anyone that that wants to support the function of the central nerv=
ous
system and the energy production in all cells.
Q. Who is Georg Birkmayer?
A. Professor Georg Birkmayer, MD, Ph.D., is the director of a clinica=
l
laboratory in Vienna, Austria as well as a world renowned biochemical
researcher. He is associated with the University of Vienna and is a v=
isiting
professor at the University of Beijing, China. He is the general secr=
etary
of the International Academy of Tumor Marker Oncology. In addition to=
being
a practicing physician, he is the author of more than 100 scientific
articles.
References:
1. Lehninger, A.L. (1970): Biochemistry, Worth Publisher Inc. 1970.
2. Klingenberg M. (1960): Zur Bedeutung der freien Nucleotide. 11.Moo=
sbacher
Kolloquium Springer Verlag p. 82-114
3. Sauberlich H.E. (1987): Nutritional Aspects of Pyridine Nucleotide=
s, in
Dolphin D, Poulson R., Avramovic O. (editors): Pyridine Nucleotide Co=
enzymes
(Part B), John Wiley & Sons, Inc. 1987, p. 599-626
4. Alberts B, et al (1983): Molecular Biology of the Cell, Garland
Publishing, 1983, p. 491-495.
5. Vrecko K., Birkmayer JGD and Krainz J. (1993): Stimulation of dopa=
mine
biosynthesis in cultured PC12 phaeochromocytoma cells by the coenzyme
nicotinamide adenine dinucleotide (NADH), J. Neur. Trans. 5:147-156
6. Gardier M. (1994) Study Report to Labor Birkmayer, Department
Pharmacology, University Paris Sud.
7. Kaplan N.O. (1960) in Boyer PD, Lardy H. and Myrbaeck K.: The Enzy=
mes
Vol. 3, Ac Press New York p. 156-172
Colloidal NaDH, Order Form
Home Page
---------------------------------------------------------------------=
-------
Copyright =A91996-97 by Chronic Wellness International=99
Last Updated 5/10/97
